The impact features of the drug "Vetmycoderm" on some morphological, biochemical and immunological blood parameters in dogs with dermatomycosis

Abstract

Among the derivatives of 1,2,4-triazole, many compounds exhibit biological activity[1, 2], and some of them are active ingredients in wellknown drugs.[3] In 2022, a veterinary drug in the form of a liniment, «Vetmycoderm», was registered, and its active substance belongs to the derivatives of 1,2,4-triazole. The drug is recommended for dermatological conditions in domestic animals.[4] The problem of dermatomycoses in dogs is quite widespread. This disease can be accompanied by hematopoietic, allergic disorders, as well as suppression of autoimmune reactions. Under the influence of the vital products of microorganisms and fungi, toxic manifestations in the morphological indicators of animal blood can be observed.